What Sophion Bioscience does

Sophion Bioscience is a Danish life-science instrumentation company founded in 2000 that develops and manufactures automated patch clamp (APC) systems used in ion channel research and drug discovery. Its core product portfolio spans three hardware platforms — QPatch Compact for academic and detailed ion channel characterization, QPatch for medicinal chemistry and primary screening, and the high-throughput Qube 384 (384-well) for large-scale screening campaigns — supplemented by proprietary consumables (QPlates, QChips), add-on modules (optogenetics, temperature control, Sophion Hive data management, stacker), validated cell lines and Ringer's solutions, and a new organ-on-a-chip product called Ethica M for cardiac and muscle contractility assays.

The company monetizes through a mix of capital equipment sales, recurring consumables tied to the installed base, multi-year service and support contracts, and a Technology Access Program that lets researchers use Sophion's platforms and expertise. Go-to-market combines direct enterprise field sales out of Denmark, the US, Japan, and China with distribution partners in Korea (IWOO Scientific) and India (Marsap Services), supplemented by a scientific community-building program anchored on the Ion Channel Modulation Symposium (ICMS) and the Sophion Academy training and grants platform.

Sophion sells primarily to pharmaceutical and biotech companies, contract research organizations (including Charles River, Evotec, Metrion Biosciences, and B'SYS), and academic institutions, with secondary verticals in agrochemical, food and beverage, and cosmetics safety testing. The company is privately held, ISO 9001:2015 certified, operates with 101-250 employees, and maintains wholly-owned subsidiaries in the US, Japan, and China alongside its Ballerup, Denmark headquarters. No venture or private equity funding rounds, acquisitions, or parent company relationships were disclosed.

Name

Sophion Bioscience

Legal name

Sophion Bioscience A/S

Website

https://sophion.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Sophion Bioscience is a Danish privately-held life-science instrumentation company that designs and manufactures automated patch clamp systems, proprietary consumables, and organ-on-a-chip products for ion channel research and drug discovery, serving pharmaceutical companies, CROs, and academic institutions globally.

Ownership category

akta.pro rank

Product category

Scientific Laboratory Instruments (Automated Patch Clamp)

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

Keywords

• Automated patch clamp
• Ion channel research
• Electrophysiology instrumentation
• Drug discovery platforms
• Laboratory automation systems

Headquarters

HQ city

Ballerup

HQ country

Denmark

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Automated Patch Clamp Instruments: Sale of hardware instruments including QPatch Compact, QPatch, and Qube 384 platforms. These are precision scientific instruments sold to pharmaceutical companies, CROs, and academic institutions for ion channel research.
2. Consumables: Ongoing sales of consumables including QPlates and QChips that are used with the automated patch clamp instruments. Creates recurring revenue stream from installed customer base.
3. Service & Support Plans: Technical support, application support, and service contracts to ensure maximum instrument uptime and customer productivity.
4. Technology Access Program: Program allowing researchers to access Sophion's platforms and expertise in their labs, providing flexible engagement options for customers.
5. Cell Lines and Ringer's Solutions: Validated and optimized cell lines and solutions for use across Sophion's automated patch clamp platforms.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels7 records

Core offering

Sophion Bioscience designs, manufactures, and sells automated patch clamp (APC) instrumentation, consumables, biological reagents, and supporting software and services for ion channel research and drug discovery. Its core offerings are the QPatch Compact, QPatch, and Qube 384 APC platforms, the Ethica M organ-on-a-chip contractility system, proprietary QPlates and QChips consumables, validated cell lines and Ringer's solutions, the Sophion Hive data management platform, and service & support plans plus a Technology Access Program for laboratory customers.

Product overview

Sophion Bioscience offers a complete automated patch clamp solution portfolio for ion channel research and drug discovery. The core platform lineup includes QPatch Compact and QPatch (manual-to-automated systems for academic research and primary screening) and Qube 384 (high-throughput system for large screening campaigns). These platforms are complemented by proprietary consumables (QPlates, QChips), add-on modules (QPC Opto 465 for optogenetics, QPrep, Sophion Hive, Temperature Control, Adaptive Current Clamp, Rs Compensation, Qube 384 Stacker, Virtual Qube), and biological consumables (validated cell lines and Ringer's solutions). The company also offers Ethica M, an organ-on-a-chip contractility solution for replicating human heart and muscle function. Full customer services include service & support plans and a Technology Access Program.

Differentiator

Problem solved

Functional benefit

Brands

• ICMS (Ion Channel Modulation Symposium): Annual international symposium series organized by Sophion Bioscience bringing together researchers from academia, CROs, and pharmaceutical industry to discuss ion channel modulation research

Products and services

• QPatch Compact Automated patch clamp (APC) instrument designed for academic research and detailed ion channel characterization, delivering faster, more accurate and objective patch clamp results independent of user skill. Sold to academic institutions, pharmaceutical companies, and CROs.
• QPatch Automated patch clamp platform for medicinal chemistry iteration and primary screening, enabling faster turnaround of electrophysiology data for drug discovery programs. Targeted at pharmaceutical and CRO customers running compound screening.
• Qube 384 High-throughput automated patch clamp platform with 384-well capacity, designed for maximum throughput and efficiency in large-scale ion channel screening campaigns; supports unattended overnight operation. Sold to pharmaceutical companies, CROs, and academic core facilities running high-volume screening.
• Ethica M Organ-on-a-chip contractility solution that replicates human heart and muscle function with high throughput, providing faster, more ethical drug discovery with better predictions and lower costs. Sold to pharmaceutical, CRO and academic researchers in cardiac and muscle safety research.
• QPlates Proprietary plate consumables designed for use with Sophion automated patch clamp systems, sold as ongoing consumables to customers with installed QPatch instruments.
• QChips Chip consumables for the Qube 384 platform, usable in full or partial configurations (starting from 96 wells, scaling in 32-well increments) to optimize consumable usage and reduce waste. Sold as recurring consumables to Qube 384 customers.
• Cell Lines Validated and optimized cell lines for use across Sophion automated patch clamp platforms, providing consistent and reproducible results for ion channel research. Sold to instrument customers as a recurring biological consumable.
• Ringer's Solutions Ringer's solutions validated and optimized for use across Sophion automated patch clamp platforms, providing best results in ion channel recordings. Sold as a recurring consumable to instrument customers.
• Sophion Service & Support Plans Comprehensive technical and application service plans offering fast response times, application support, and maximum instrument uptime to support laboratory productivity for Sophion customers. Sold via multi-year service contracts to the installed base.
• Technology Access Program Program providing researchers access to Sophion's automated patch clamp platforms and technical expertise in Sophion's laboratories, enabling flexible engagement and evaluation without capital purchase. Sold as a services engagement to pharmaceutical, CRO and academic researchers.

Quantifiable outcome

• Researchers can test 8 compounds on 3 ion channels with full dose responses in one day, compared to testing 1 compound on 1 ion channel with manual patch clamp
• +1 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Five partnerships are on record, tiered core, strategic and minor.

• IWOO ScientificcoreChannel Partner/ Reseller/ DistributorIWOO Scientific Corporation is Sophion's authorized distributor in South Korea, providing local sales, support, and service for Sophion's automated patch clamp solutions to Korean customers. Located at 5F, 30, Banpo-daero 23-gil, Seocho-gu, Seoul 06656.
• Marsap ServicescoreChannel Partner/ Reseller/ DistributorMarsap Services Pvt. Ltd. is Sophion's authorized distributor in India, providing local sales, support, and service for Sophion's automated patch clamp solutions to Indian customers. Located at 29, Ujagar Industrial Estate, W.T.P. Marg, Deonar, Mumbai.
• CytoCyberneticsstrategicTechnology or IntegrationCytoCybernetics collaborated with Sophion on a webinar demonstrating integration of Sophion's QPatch automated patch clamp data with CytoCybernetics' CyberQ-qNet workflow for CiPA-based in silico cardiac safety evaluation. Dr. Randall Rasmusson from CytoCybernetics presented alongside Sophion's Dr. Patric Vaelli.
• Boehringer IngelheimminorStrategic or Co-development PartnerBoehringer Ingelheim is connected to Sophion through Dr. Nadia von Schoubye's lab, which is supporting Nikolaos Oikonomopoulos' research grant at Sophion's Copenhagen labs focused on primary neuron APC assays for drug discovery.
• Ulm UniversityminorStrategic or Co-development PartnerUlm University in Germany is the academic institution of Nikolaos Oikonomopoulos, who is conducting research on primary neuron APC assays at Sophion's Copenhagen labs through a research grant, bridging academia and industry.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Molecular Devices: Direct competitor in automated patch clamp with the IonWorks and PatchXpress platforms. Now part of Danaher, Molecular Devices sells a broader portfolio of life science instruments and benefits from greater scale and bundling leverage than Sophion.
• Axion Biosystems: Provides the Maestro multi-electrode array (MEA) platform for electrophysiology and cardiac safety. Axion competes with Sophion for preclinical cardiac safety and neuroscience screening budgets.
• Nanion Technologies: Germany-based direct competitor in automated patch clamp with Port-a-Patch, Patchliner, and SyncroPatch 384i. Nanion competes head-to-head with Sophion across academic, CRO, and pharma segments for ion channel screening instruments.
• HEKA Elektronik (Harvard Bioscience): Long-established manufacturer of patch clamp and electrophysiology amplifiers (EPC series). HEKA competes with Sophion in the academic and detailed ion channel characterization segments, particularly for manual-to-automated workflows.
• Multi Channel Systems (Harvard Bioscience): Provides MEA and electrophysiology recording systems for cardiac and neuroscience screening. MCS overlaps with Sophion in cardiac safety profiling and academic ion channel research applications.
• Fluxion Biosciences: Direct competitor offering the IonFlux automated patch clamp platform for ion channel research. Fluxion targets similar pharma, CRO, and academic customers with a differentiated well-plate-based APC architecture.

Emerging players

• MaxWell Biosystems: Swiss-based developer of high-density CMOS-MEA chips for neuronal recording and drug discovery. MaxWell targets overlapping pharma/neuroscience screening budgets with a complementary (not directly substitutable) technology to Sophion's APC.
• CytoCybernetics: Provides the CyberQ-qNet in silico cardiac safety evaluation workflow that integrates with Sophion's QPatch for CiPA-based assessment. A technology integration partner rather than head-to-head competitor, but addresses the same cardiac safety procurement budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sophionbio
• LinkedInlinkedin.com/company/sophion-bioscience-as

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sophion Bioscience